Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.
The global Pneumococcal Vaccine Polyvalent market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pneumococcal Vaccine Polyvalent volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Vaccine Polyvalent market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pneumococcal Vaccine Polyvalent in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pneumococcal Vaccine Polyvalent manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck & Co.
Pfizer
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Prevnar 13
Pneumovax23
Segment by Application
18 years and younger
19 to 64 years old
65 years and older
Summary:
Get latest Market Research Reports on Pneumococcal Vaccine Polyvalent. Industry analysis & Market Report on Pneumococcal Vaccine Polyvalent is a syndicated market report, published as Global Pneumococcal Vaccine Polyvalent Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Pneumococcal Vaccine Polyvalent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.